Cite
MLA Citation
Andrew J Brenner et al.. “ACTR-17. EVOPHOSPHAMIDE (TH-302) FOR RECURRENT GBM FOLLOWING BEVACIZUMAB FAILURE, FINAL RESULTS OF A MULTICENTER PHASE II STUDY.” Neuro-oncology, vol. 20, n.d., pp. vi14–vi15. http://access.bl.uk/ark:/81055/vdc_100095323619.0x00001d